Clinical Trials Browser

CX 5461 × Genitourinary × Clear all

NCT04890613 2026-04-28

Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation

Phase 1 Recruiting

BreastGastrointestinalGenitourinaryGynecologic

Breast Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms

NCT05425862 2023-12-11

REPAIR

Phase 1 Suspended

Metastatic Castration Resistant Prostate Cancer (mCRPC)